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a b s t r a c t
To feed or breathe, the oral opening must connect with the gut. The foregut and oral tissues converge at
the primary mouth, forming the buccopharyngeal membrane (BPM), a bilayer epithelium. Failure to form
the opening between gut and mouth has signiﬁcant ramiﬁcations, and many craniofacial disorders have
been associated with defects in this process. Oral perforation is characterized by dissolution of the BPM,
but little is known about this process. In humans, failure to form a continuous mouth opening is
associated with mutations in Hedgehog (Hh) pathway members; however, the role of Hh in primary
mouth development is untested. Here, we show, using Xenopus, that Hh signaling is necessary and
sufﬁcient to initiate mouth formation, and that Hh activation is required in a dose-dependent fashion to
determine the size of the mouth. This activity lies upstream of the previously demonstrated role for Wnt
signal inhibition in oral perforation. We then turn to mouse mutants to establish that SHH and Gli3 are
indeed necessary for mammalian mouth development. Our data suggest that Hh-mediated BPM
persistence may underlie oral defects in human craniofacial syndromes.
& 2014 Elsevier Inc. All rights reserved.
Introduction
To feed or breathe the oral opening must connect with the
gut. The primary mouth marks the location of this interface,
and perforation is essential (Dickinson and Sive, 2006; Hardin
and Armstrong, 1997; McClay et al., 1992; Poelmann et al., 1985;
Soukup et al., 2013; Takahama et al., 1988; Watanabe et al., 1984).
Despite the fundamental importance of the primary mouth,
little is known about the molecular control of its development.
In mammals, the buccopharyngeal membrane (BPM) is hidden
internally, behind the expanding facial prominences and is sur-
rounded by the brain and cardiac tissues, making mammalian
primary mouth development a challenging process to investi-
gate (Poelmann et al., 1985; Soukup et al., 2013; Theiler, 1969;
Waterman, 1977). However, a series of elegant studies have shown
that Xenopus laevis is a tractable model for understanding primary
mouth development (Dickinson and Sive, 2007, 2006, 2009; Jacox
et al., 2014; Kennedy and Dickinson, 2014).
In mammals and amphibians the mouth opening forms as a
result of contact between invaginating primary mouth ectoderm
and foregut endothelium (Fig. 1A) (Dickinson and Sive, 2006,
2009; Soukup et al., 2013; Waterman, 1977, 1985; Waterman
and Schoenwolf, 1980). In Xenopus, invaginating ectoderm appears
as a depression called the stomodeum (Dickinson and Sive, 2006),
and this depression deepens as apoptosis and cell intermingling
thin the epithelium (Dickinson and Sive, 2006, 2009; Poelmann
et al., 1985). The basement membrane (BM) separating foregut
endoderm and stomodeal ectoderm dissolves to permit intercala-
tion of the epithelial bilayer and subsequent oral perforation
(Dickinson and Sive, 2006, 2009; Soukup et al., 2013; Waterman,
1977, 1985; Waterman and Schoenwolf, 1980) (Fig. 1).
At present, only a single signaling system has been identiﬁed as a
molecular regulator of primary mouth development. In Xenopus, Wnt
signal inhibition is necessary for stomodeal speciﬁcation and perfora-
tion (Dickinson and Sive, 2009). Wnt/β-catenin signaling is necessary
to promote transcriptional activation of the basement membrane
component ﬁbronectin (FN) (Gradl et al., 1999), while Wnt inhibitors
Crescent and Frzb-1 are required within the stomodeum for dissolu-
tion of the basement membrane separating foregut endoderm and
oral ectoderm (Dickinson and Sive, 2009). Loss of either inhibitor
results in a small, imperforate primary mouth. Concomitantly, facial
Wnt-8 gain-of-function is sufﬁcient to suppress stomodeum forma-
tion (Dickinson and Sive, 2009). However, the stomodeal ectoderm
becomes unresponsive to Wnts long before perforation, suggesting
that Wnts do not directly control mouth opening (Dickinson and
Sive, 2009). Therefore, it is necessary to consider other signaling
pathways during primary mouth morphogenesis.
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In mammals, virtually nothing is known about the molecular
control of primary mouth formation, but several craniofacial syn-
dromes, including CHARGE, Down, Holzgreve–Wagner–Rehder,
Greig cephalopolydactyly syndrome (GCPS) and synostotic syn-
dromes, as well as cleft palate, have been associated with persistent
BPM (Kliegman, 2011; DéMurger et al., 2014; Pillai et al., 1990;
Verma and Geller, 2009). Notably, Holzgreve–Wagner–Rehder syn-
drome involves cleft palate and postaxial polydactyly, phenotypes
associated with Hh perturbation (Legius et al., 1988). Furthermore, a
recent publication reports that GCPS—characterized by mutations in
the Hh effector Gli3—caused oral anomalies in all prenatal cases
observed, and in one instance a complete absence of the oral
opening (DéMurger et al., 2014). We therefore tested the require-
ments for Hedgehog signaling during primary mouth development.
We present data suggesting that Hh signaling is required for BPM
dissolution in both Xenopus and mouse. Moreover, we show that Hh
Fig. 1. Hedgehog perturbation affects the size of the oral opening. (A) Schematic illustrating primary mouth development. Frontal view of Xenopus tadpole indicates sectional
plane for schematics. Stage 12.5, primary mouth induction occurs anterior to the prechordal plate (PP), notochord (Nc) and neural plate (NP). Stage 19 foregut endoderm (Fg)
abuts mouth ectoderm (Ec, pink), separated by ﬁbronectin-rich basement membrane (BM, green), between forebrain (Fb) and cement gland (CG). BM dissolves and
mesenchymal clearance thins stomodeum (green dashed line indicates BM). Stage 37, buccopharyngeal membrane (BPM) formation. Stage 40, BPM perforation. (B–D) Frontal
view of stage 45 tadpoles incubated from 2-cell stage with 10 μM (B), 5 μM (C), or 2 μM SANT1 (D) (B, n¼13/13, C, n¼16/16, D, n¼15/15). Primary mouth is indicated by red
arrowhead. (E) Control tadpole, 0.07% DMSO (n¼26/26). (F–H) Tadpoles incubated with 2 μM (F), 20 μM (G) or 100 μM purmorphamine (H). Increase in mouth size was
observed with increasing concentrations of purmorphamine (F, n¼70/70, G, n¼43/43, H, n¼154/154). (I) Quantiﬁcation of mouth size for 10 μM, 5 μM, or 2 μM SANT1, 0.07%
DMSO, 2 μM, 20 μM or 100 μM purmorphamine, where mouth perimeter is normalized to width of the head. nnnnPo0.001. Scheme indicating primary mouth size (green) in
relationship to Hh activity (red bar). (J) Stage 45 control tadpole. (Jʹ) Facial anatomy schematic. (K–N) Tadpoles incubated with 250 μM cyclopamine from 2-cell stage (K),
between stages 12.5–19 (L), 19–37 (M), or from 37 (N). (O–R) Tadpoles treated with 100 μM purmorphamine from the 2-cell stage (O), between stages 12.5–19 (P), 19–37 (Q),
or from stage 37 (R).
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signaling is required in a dose-dependent fashion to control base-
ment membrane dissolution and endoderm–ectoderm intercala-
tion. These data signiﬁcantly advance our understanding of primary
mouth development and pinpoint a novel role for Hh signaling
during this process.
Results and discussion
Hedgehog is required for primary mouth perforation
In Xenopus, the primary mouth is externally accessible and
offers a tractable system for studying oral perforation (Dickinson
and Sive, 2006). Moreover, Xenopus embryos are easily treated
with chemical modulators. Thus, early effects of Hh perturbation
can be readily bypassed (Hollemann et al., 2007; Lewis and Krieg,
2014; Peyrot et al., 2011). We asked whether Hh loss of function,
using the potent inhibitor cyclopamine or SANT1, could perturb
primary mouth development (Chen et al., 2002; Peyrot et al., 2011;
Williams et al., 2003). Indeed, incubation with either cyclopamine
or SANT1 resulted in ablation of the stomodeum and the primary
oral opening (Fig. 1B–D compared to E). Hh pathway activation is
therefore essential for primary mouth development.
Hedgehog regulates primary mouth size
As loss of Hh activation resulted in a small or absent primary
mouth, we asked whether increasing the levels of Hh could
modulate mouth size. Purmorphamine is a well-established Hh
agonist (Dessaud et al., 2007; Sinha and Chen, 2006; Stanton and
Peng, 2010), and continuous incubation of embryos with purmor-
phamine caused a dramatic increase in primary mouth size
(Fig. 1F–H compared to E, and I). Therefore, Hh activation is both
necessary and sufﬁcient to drive an increase in mouth size. This
effect on oral size was speciﬁc, as both inhibition and activation
of Hh signaling, from the 2-cell stage, resulted in broadly similar
changes in head proportions (Supplemental Fig. S1D and E);
despite this, cyclopamine and purmorphamine had opposing
effects on the oral opening. Furthermore, the cement gland and
nasal pits, two anterior structures that develop in close proximity
to the mouth, were not dramatically altered upon either treatment
(Fig. 1B–H and Supplemental Fig. S1A–C). These data suggest that
Hh-mediated regulation of primary mouth development is speciﬁc
to the mouth, and can be uncoupled from early morphogenetic
defects elsewhere in the craniofacial region.
We then tested whether mouth size is sensitive to graded levels
of Hedgehog signaling by applying a range of drug dosages
(Fig. 1B–I). To quantify the change in mouth size we measured
the perimeter of the stomodeum after incubation with 2, 5 or
10 μM SANT1, 0.7% DMSO (control), or 2, 20, 100 μM purmorpha-
mine. As incubation with either Hh modulator signiﬁcantly
decreased head size (Fig. S1E–F) we chose to normalize mouth
perimeter to the width of the head, measured as the distance
between the outer edges of the eyes. We found that increasing
levels of purmorphamine caused a dose dependent enlargement in
primary mouth size (Fig. 1F–I). Conversely, cyclopamine or SANT1
treatments caused a dose dependent reduction or complete loss of
the stomodeum (Fig. 1B–I). Together, these data suggest that an
intermediate level of Hh activation is required to determine
normal mouth size.
The oral opening is sensitive to Hedgehog throughout development
Previous studies have shown that primary mouth speciﬁcation
is susceptible to Wnt manipulation for a short time window, up to
stage 24, prior to appearance of the stomodeum (Dickinson and
Sive, 2009). Therefore, we asked whether Hh activation functions
throughout primary mouth development or during a brief period.
We tested sensitivity to Hh perturbation during induction, base-
ment membrane dissolution, or perforation stages by treating with
either drug from the 2-cell stage, between stages 12 and 19, stages
19 and 37, or from stage 37 (see Fig. 1A). At all stages up to
perforation, we found that purmorphamine treatment was sufﬁ-
cient to increase mouth size (Fig. 1N–Q). In contrast, tadpoles were
sensitive to Hh inhibition only until perforation stages (stage 37)
(Fig. 1I–M). This suggests that initial speciﬁcation of the mouth
requires early Hh activation. However, perforation of the mouth
may be separately controlled as a later increase in Hh signaling is
sufﬁcient to expand mouth size.
Hedgehog signaling regulates stomodeal basal lamina dissolution
We next sought to understand the cell biological mechanism of
Hh action during primary mouth development. Prior to intercala-
tion stages, a basement membrane comprising ﬁbronectin and
laminin separates endoderm and ectoderm (Dickinson and Sive,
2006), and the buccopharyngeal membrane forms after contact
between the foregut endoderm with stomodeal ectoderm. Endo-
derm–ectoderm contact initiates basal lamina dissolution, which
permits cell intercalation prior to perforation (Dickinson and Sive,
2006). Therefore, we considered whether the basement mem-
brane component ﬁbronectin was maintained after cyclopamine or
SANT1 treatment. Fibronectin immunoreactivity marks the sto-
modeal BM at stage 24 (Fig. 2B), which is lost by stage 26 (Fig. 2E).
After cyclopamine treatment, basement membrane ﬁbronectin
was maintained at stage 26 (Fig. 2A and D), suggesting that Hh
is necessary for basement membrane dissolution.
This raised the possibility that increasing Hh activation might
ectopically promote basement membrane dissolution. Indeed, in
contrast to control and cyclopamine treatments, ﬁbronectin was
signiﬁcantly diminished or completely absent in stage 24 purmor-
phamine treated embryos (Fig. 2C). Therefore, Hh is necessary and
sufﬁcient to promote basement membrane dissolution. Precocious
loss of the basement membrane could promote premature endo-
derm–ectoderm mixing and increase the duration or amount of
intercalation. This mechanism is consistent with our observations that
increased Hh activity causes a dose dependent increase in mouth size.
Previous studies suggested that basement membrane mainte-
nance reduces mouth size by inhibiting endoderm–ectoderm inter-
calation and buccopharyngeal membrane formation (Dickinson and
Sive, 2009). This prompted us to examine the BPM: in stage 39
control embryos, a one-cell thick BPM is observed indicating that
endoderm and ectoderm cells have intercalated into a single cell
layer (Fig. 2B). In contrast, after cyclopamine treatment, endoderm
and ectoderm were morphologically distinct (Fig. 2A), and the
intervening mesenchyme was still present. This phenotype is
consistent with a lack of mesenchymal clearance and intercalation,
and suggests that Hh is required for timely BM dissolution and BPM
formation.
As BM maintenance can inhibit intercalation in the stomo-
deum, we hypothesized that premature BM dissolution could
promote intercalation and premature perforation. We compared
purmorphamine treated embryos to controls at stage 39, when the
buccopharyngeal membrane is evident but has thinned. The BPM
was absent in embryos treated with purmorphamine (compare
Fig. 2L to K). Therefore, Hh activation is sufﬁcient to promote
premature perforation and primary mouth opening.
Stomodeal inhibition of Wnt is downstream of Hh signaling
Basement membrane dissolution is expedited after either gain
of Hh signaling (Fig. 2) or loss of the Wnt inhibitors Frzb-1 and
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Crescent (Dickinson and Sive, 2009). Our data suggest that Hh
signals are required for stomodeal formation during an earlier
developmental window than that reported for stomodeal Frzb-1 or
Crescent. Therefore, we asked if Wnt signal inhibition functions
downstream of Hh activation in determining primary mouth size
(Fig. 3). In this case, activation of Wnt should be able to rescue
mouth enlargement caused by Hh gain of function. To test this, we
ﬁrst treated embryos with DMSO or purmorphamine at the 2-cell
stage. After washout at stage 12.5 or 19, embryos were treated
with a glycogen synthase kinase-3 (GSK-3) inhibitor, BIO, which
activates β-catenin dependent Wnt signaling (Meijer et al., 2003).
Consistent with previous reports on Wnt inhibition (Dickinson and
Sive, 2009), BIO treatment during neurulation (stage 12.5–19),
after incubation with DMSO (2 cell-stage-12.5), caused a complete
loss of the mouth (Fig. 3B), while BIO treatment from stage 19 did
not affect mouth size (Fig. 3C). Embryos treated with BIO from
Fig. 2. Hedgehog signaling is necessary and sufﬁcient for basement membrane dissolution. (A–C, E–Gʹ) Sagittal sections through primary mouth stained for β-catenin in
magenta, ﬁbronectin (FN) and nuclei in green. (Fg) foregut, (BM) basement membrane, (Fb) forebrain, (Cg) cement gland. (A–C) Stage 24. (A) Embryo treated with 10 μM
SANT1 from the 2-cell stage. (Aʹ) Magniﬁed view of endoderm–ectoderm interface and basement membrane. FN is observed (white arrowhead) (n¼7). (B) Control. (Bʹ) FN
immunoﬂuorescence indicates the presence of BM between foregut and ectoderm (white arrowhead, n¼7). (C) Embryo treated with 250 μM purmorphamine. (Cʹ) No FN
immuoﬂuorescence is observed between foregut and ectoderm (open white arrowhead, n¼6/7). (D–Dʹ) Schematic indicating anatomy of sections represented in B–Bʹ.
Fibronectin-rich basement membrane separates foregut and ectoderm. (E–Gʹ) Stage 26. (E) Embryo treated with 10 μM SANT1. (Eʹ) shows persistent FN immunoﬂuorescence
(white arrowhead, n¼8). (F) Stage 26 control. (Fʹ) Almost no BM FN is observed in controls (open arrowhead, n¼12). (G) Stage 26 embryo treated with 100 μM
purmorphamine. (Gʹ) No FN immuoﬂuorescence is observed (open white arrowhead, n¼10). (H–Hʹ) Schematic indicating anatomy of WT sections represented in F–Fʹ.
Fibronectin-rich basement membrane is absent or broken, foregut and ectoderm cells mix (red arrow). (J–L) Sagittal sections of stage 39 tadpoles stained for β-catenin
(magenta) and DAPI. (J) Tadpole treated with 10 μM SANT1 (n¼5). (K) Control tadpole. BPM is observed as a single layer epithelium (n¼6). (L) Tadpole treated with 100 μM
purmorphamine. No BPM is present (n¼4). Scale bars indicate 50 μm. (M) Schematic indicating anatomy of WT sections represented in (K). Buccopharyngeal membrane
(BPM) separates foregut from external environment and indicates site of future mouth.
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stage 12.5, after incubation with purmorphamine, showed a
reversal of purmorphamine induced stomodeal expansion, with
a complete loss of the oral opening (compare Fig. 3E to D).
Conversely, BIO treatment from stage 19, after incubation with
purmorphamine, was unable to reverse the effect of increased Hh
signaling (Fig. 3F). These data suggest that stomodeum is refrac-
tory to inhibition of Wnt signals after stage 19, consistent with
previous reports showing that Frzb-1/Crescent needs to be down
regulated after stage 19 (Dickinson and Sive, 2009).
As Hh and Wnt signaling function antagonistically in many
contexts (Akiyoshi, 2006; Cain et al., 2009; He et al., 2006; Lee
et al., 2000; Varnat et al., 2010; Wheway et al., 2013), we propose
that SHH signals, expressed in the prechordal plate (Ekker et al.,
1995), activates facial Wnt inhibitor expression, such as Crescent and
Frzb-1, which in turn mediates basal lamina dissolution (Dickinson
and Sive, 2009). As prolonged Hh signaling causes continued
enlargement of the mouth, but Wnt sensitivity is short-lived, Hh is
likely to act independently of Wnt during later oral opening (Fig. 4D).
Hh regulates mammalian BPM perforation
Our data demonstrate a key role for Hh signaling in Xenopus
mouth development; genetic evidence suggests that this is also
the case in humans (DéMurger et al., 2014; Legius et al., 1988). To
ask if Hh loss of function might perturb mammalian BPM perfora-
tion, we examined mice mutant for Sonic hedgehog (Shh).
In humans, the BPM disappears by 15 days gestation, while in
mice perforation of the BPM occurs by the 17-somite stage at E9
(Poelmann et al., 1985; Theiler, 1969; Standring, 2009). Strikingly,
cross sections of E9 embryos revealed that the BPM was inappro-
priately retained in Shh mutants (Fig. 4C).
In humans, Greig cephalopolydactyly (GCPS) and Pallister–Hall
syndromes are caused by mutation of the Hedgehog effector Gli3
(DéMurger et al., 2014; Legius et al., 1988). Both syndromes are
associated with an absence of oral perforation (DéMurger et al.,
2014). We examined BPM perforation using mice carrying the
Gli3xt-J allele which models GCPS (Hui and Joyner, 1993). We found
that loss of Gli3 in this mutant was sufﬁcient to retard dissolution of
the BPM (Fig. 4D and E). This outcome is of interest because it
provides insights into the mechanism of Gli3 action. Biochemically,
Gli3 is a transcription factor; it is believed that in the absence of Hh,
Gli3 represses Hh target genes, while Hh activation converts Gli3
into a transcriptional activator (Blaess et al., 2008; Wang et al.,
2007). Our data are notable because in the context of human Gli3
mutations, it has been unclear whether the oral phenotypes reﬂect a
requirement for Gli3 as a transcriptional activator or as a repressor
(DéMurger et al., 2014). Because BPM persistence in Gli3xt-J/xt-J mice
phenocopies Shh mutant mice, our data support the argument that
Gli3 acts as a transcriptional activator during oral perforation.
Anatomical characterization in diverse systems including sea
urchins, urodeles, Xenopus, and mouse have suggested that inter-
actions between foregut and stomodeal ectoderm are impor-
tant for oral perforation (Dickinson and Sive, 2006; Hardin
and Armstrong, 1997; McClay et al., 1992; Poelmann et al., 1985;
Soukup et al., 2013; Takahama et al., 1988; Theiler, 1969; Watanabe
et al., 1984; Waterman, 1977). However, molecular regulation of
primary mouth opening is largely untested, especially as perfora-
tion occurs early in development and perturbation of major
signaling cascades results in broad cranial defects. Moreover,
because the mammalian primary mouth develops internally,
defects in its development are obscured by secondary oral phe-
notypes. Indeed, the evidence of human BPM anomalies is pri-
marily anecdotal and persistent BPM is frequently unreported due
to the severity of associated phenotypes (Verma and Geller, 2009).
Taken together, we provide the ﬁrst demonstration of a role for
HH signaling in primary mouth development, and moreover we
provide the ﬁrst data directly revealing a molecular mechanism in
mammalian BPM development. Our data suggest that HH and Gli3
are required to drive basement membrane dissolution, endoderm–
ectoderm intercalation and perforation of the primary mouth.
These experiments also illustrate the feasibility of using Xenopus to
provide testable hypotheses in mammals. Combined, these data
provide novel evolutionary insights into the genetic regulation
governing oral opening, and may be relevant to poorly studied
human anomalies, such as persistent BPM and atresia.
Materials and methods
Animals
X. laevis embryos were cultured using standard methods (Sive
et al., 2000). Staging was according to Nieuwkoop and Faber
(1994). Shh mutants were initially generated by crossing ﬂoxed
mutants to Sox2-Cre (Lewis et al., 2001). Gli3xt-J is a spontaneously
occurring intergenic deletion of Gli3 (Hui and Joyner, 1993). Mice
were a kind gift from Dr. Steven Vokes.
Chemical inhibitors
Xenopus embryos were incubated in 12-well plates, 10 embryos
per well. For Hh perturbation 250 μM, 50 μM, or 5 μM cyclopamine
Fig. 3. Wnt inhibition acts downstream of Hh signaling during BPM dissolution. (A–
F) Stage 38 tadpoles. (A) Control tadpole incubated with 0.7% DMSO continuously
from 2-cell stage. (B) Tadpole incubated with 0.7% DMSO, then 15 μM BIO from stage
12.5 (n¼34). (C) Tadpole incubated with 0.7% DMSO, then 15 μM BIO from stage 19
(n¼34). (D) Tadpole incubated with 100 μM purmorphamine, then 0.07% DMSO
from stage 12.5 (n¼34). Primary mouth is enlarged. (E) Tadpole incubated with
100 μM purmorphamine, then 15 μM BIO from stage 12.5 (n¼34). (F) Tadpole
incubated with 100 μM purmorphamine, then 15 μM BIO from stage 19 (n¼34).
Scale bars indicate 100 μm. (G) Schematic indicating drug application scheme and
outcome. Red arrowheads (B and E) indicate absence of primary mouth.
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(Cayman Chemicals), 20 μM, 5 μM, or 2 μM SANT1 (Sigma), or
2 μM, 20 μM, or 100 μM purmorphamine (inSolution, Sigma) were
added to media. Control embryos were incubated in 0.7% DMSO in
media. For single dose experiments 250 μM cyclopamine, 20 μM
SANT1 and 100 μM purmorphamine were used.
Immunohistochemistry
Immunohistochemistry was performed according to standard
protocols using a polyclonal anti-β-catenin antibody (Santa Cruz
7199) or monoclonal 4H2 anti-ﬁbronectin antibody (1:200)
(Danker et al., 1993) (kind gift from Douglas DeSimone), revealed
by an Alexa Fluor-conjugated secondary antibody (1:200). DNA
was visualized with 0.1% DAPI. Embryos were cleared in benzyl
benzoate:benzyl alcohol and staining visualized using a Zeiss 700
microscope.
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Fig. 4. Sonic hedgehog and Gli3 are required for perforation of the mammalian BPM. (A) Schematic frontal view of E9.0 mouse embryo. Dashed line indicates section plane.
(B) Schematic of section. Red box indicates region represented in panels (C) and (Dʹ). (Fb) forebrain, (Fg) pharyngeal foregut, (H) Heart. (C–D) Nuclei are stained with DAPI
(cyan) (B) Sagittal section of E9.0 (20 somite) Shhþ /þ embryo (n¼3). (Bʹ) Schematic illustrating anatomy in (B). (C) Sagittal section through E9.0 Shh / embryo (n¼3). (Cʹ)
Schematic illustrating anatomy depicted in (C). (D–E) Sagittal sections through E9.0 (19 somite) Gli3þ /þ and Gli3xt/xt embryos, respectively. Remnant buccopharyngeal
membrane (BPM) is observed in Shh / and Gli3xt/xt embryos. Nuclei are stained with DAPI (cyan). Scale bars indicate 100 μm. B–C are littermates, as are D–E. (F) Proposed
model of primary mouth formation in Xenopus. Frontal schematic indicates sectional plane of diagrams. Cyan bar indicates stages of primary mouth competence. Red bar
indicates level of Hh activation while blue indicates Wnt inhibition, where white is none, and bright color is high. Wnt inhibitors Crescent and Frzb-1 are expressed in
primary mouth ectoderm (blue). Primary mouth ectoderm is induced adjacent to Hh signal where Wnt inhibition is highest (cyan bracket). By stage 28, BM is indicated by
white outlines, and mesenchymal cells are illustrated in black. Hh signal activation (red) is highest ventral to the forebrain (Fb). (Cg) and (Fg) indicate cement gland and
foregut, respectively. Wnt inhibitors are no longer expressed, and stomodeum is refractive to Wnt activation. By stage 39, endoderm–ectoderm intercalation forms
monolayer buccopharyngeal membrane (BPM). Hh signal activation is required through intercalation stages.
J.M. Tabler et al. / Developmental Biology 396 (2014) 1–76
Funding
This work was funded by grants from Biotechnology and
Biological Sciences Research Council (BBSRC) (BB/E013872/1 and
BB/I021922/1) and Wellcome Trust (081880/Z/06/Z) to K.J.L., as
well as a King's College London Dental studentship to K.J.L. and T.B.
The National Institute of Dental and Craniofacial Research/National
Institutes of Health (NIDCR/NIH) (F32DE023272) funded J.T. Work
in the J.B.W. lab is supported by grants from the National Institute
of General Medical Sciences (GM074104)/National Heart, Lung and
Blood Institute (HL117164); J.B.W. is an Early Career Scientist of the
Howard Hughes Medical Institute.
Acknowledgments:
We are grateful to Roman Khonsari, Jordan Lewandowski and
Steven Vokes for valuable discussion and the Vokes lab for kind
gift of mice. We thank Marc Dionne for critical reading of the
manuscript.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.09.029.
References
Akiyoshi, T., 2006. Gli1, downregulated in colorectal cancers, inhibits proliferation
of colon cancer cells involving Wnt signalling activation. Gut 55, 991–999.
Blaess, S., Stephen, D., Joyner, A.L., 2008. Gli3 coordinates three-dimensional
patterning and growth of the tectum and cerebellum by integrating Shh and
Fgf8 signaling. Development 135, 2093–2103.
Cain, J.E., Islam, E., Haxho, F., Chen, L., Bridgewater, D., Nieuwenhuis, E., Hui, C.-C.,
Rosenblum, N.D., 2009. GLI3 repressor controls nephron number via regulation
of Wnt11 and Ret in ureteric tip cells. PLoS One 4, e7313.
Chen, J.K., Taipale, J., Young, K.E., Maiti, T., Beachy, P.A., 2002. Small molecule
modulation of Smoothened activity. Proc. Natl. Acad. Sci. USA 99, 14071–14076.
Danker, K., Hacke, H., Ramos, J., DeSimone, D., Wedlich, D., 1993. V(þ)-ﬁbronectin
expression and localization prior to gastrulation in Xenopus laevis embryos.
Mech. Dev. 44, 155–165.
Dessaud, E., Yang, L.L., Hill, K., Cox, B., Ulloa, F., Ribeiro, A., Mynett, A., Novitch, B.G.,
Briscoe, J., 2007. Interpretation of the sonic hedgehog morphogen gradient by a
temporal adaptation mechanism. Nature 450, 717–720.
Dickinson, A., Sive, H., 2007. Positioning the extreme anterior in Xenopus: cement
gland, primary mouth and anterior pituitary. Semin. Cell Dev. Biol. 18, 525–533.
Dickinson, A.J.G., Sive, H., 2006. Development of the primary mouth in Xenopus
laevis. Dev. Biol. 295, 700–713.
Dickinson, A.J.G., Sive, H.L., 2009. The Wnt antagonists Frzb-1 and Crescent locally
regulate basement membrane dissolution in the developing primary mouth.
Development 136, 1071–1081.
DéMurger, F.D.E., Ichkou, A., Mougou-Zerelli, S., Le Merrer, M., Goudefroye, G.E.R.,
Delezoide, A.-L., Quélin, C., Manouvrier, S., Baujat, G., Fradin, M., et al., 2014.
New insights into genotype–phenotype correlation for GLI3 mutations. Eur. J.
Hum. Genet., 1–11.
Ekker, S.C., McGrew, L.L., Lai, C.J., Lee, J.J., von Kessler, D.P., Moon, R.T., Beachy, P.A.,
1995. Distinct expression and shared activities of members of the hedgehog
gene family of Xenopus laevis. Development 121, 2337–2347.
Gradl, D., Kühl, M., Wedlich, D., 1999. The Wnt/Wg signal transducer beta-catenin
controls ﬁbronectin expression. Mol. Cell. Biol. 19, 5576–5587.
Hardin, J., Armstrong, N., 1997. Short-range cell–cell signals control ectodermal
patterning in the oral region of the sea urchin embryo. Dev. Biol. 182, 134–149.
He, J., Sheng, T., Stelter, A.A., Li, C., Zhang, X., Sinha, M., Luxon, B.A., Xie, J., 2006.
Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J. Biol.
Chem. 281, 35598–35602.
Hollemann, T., Tadjuidje, E., Koebernick, K., Pieler, T., 2007. Manipulation of
hedgehog signaling in Xenopus by means of embryo microinjection and
application of chemical inhibitors. Methods Mol. Biol. 397, 35–45.
Hui, C.C., Joyner, A.L., 1993. A mouse model of greig cephalopolysyndactyly
syndrome: the extra-toesJ mutation contains an intragenic deletion of the
Gli3 gene. Nat. Genet. 3, 241–246.
Jacox, L.A., Dickinson, A.J., Sive, H., 2014. Facial transplants in Xenopus laevis
embryos. J. Vis. Exp, Mar 26;(85).
Kennedy, A.E., Dickinson, A.J., 2014. Quantitative analysis of orofacial development
and median clefts in Xenopus laevis. Anat Rec. 297, 834–855.
Kliegman, R., 2011. Nelson Textbook of Pediatrics. W B Saunders Company,
Philadelphia, PA: Elsevier/Saunders.
Lee, C.S., Buttitta, L.A., May, N.R., Kispert, A., Fan, C.M., 2000. SHH-N upregulates
Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the
somitic mesoderm. Development 127, 109–118.
Legius, E., Moerman, P., Fryns, J.P., Vandenberghe, K., Eggermont, E., 1988. Holzgreve–
Wagner–Rehder syndrome: Potter sequence associated with persistent bucco-
pharyngeal membrane. A second observation. Am. J. Med. Genet. 31, 269–272.
Lewis, C., Krieg, P.A., 2014. Reagents for developmental regulation of hedgehog
signaling. Methods 66, 390–397.
Lewis, P.M., Dunn, M.P., McMahon, J.A., Logan, M., Martin, J.F., St-Jacques, B.,
McMahon, A.P., 2001. Cholesterol modiﬁcation of sonic hedgehog is required
for long-range signaling activity and effective modulation of signaling by Ptc1.
Cell 105, 599–612.
McClay, D.R., Armstrong, N.A., Hardin, J., 1992. Pattern formation during gastrula-
tion in the sea urchin embryo. Development 1992 Supplement, 33–41.
Meijer, L., Skaltsounis, A.-L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M.,
Ryan, X.P., Vonica, C.A., Brivanlou, A., Dajani, R., et al., 2003. GSK-3-selective
inhibitors derived from Tyrian purple indirubins. Chem. Biol. 10, 1255–1266.
Nieuwkoop, P.D., Faber, J., 1994. Normal Table of Xenopus Laevis (Daudin). Garland
Science, New York.
Peyrot, S.M., Wallingford, J.B., Harland, R.M., 2011. A revised model of Xenopus
dorsal midline development: differential and separable requirements for Notch
and Shh signaling. Dev. Biol. 352, 254–266.
Pillai, K.G., Kamath, V.V., Kumar, G.S., Nagamani, N., 1990. Persistent buccophar-
yngeal membrane with cleft palate. A case report. Oral Surg. Oral Med. Oral
Pathol. 69, 164–166.
Poelmann, R.E., Dubois, S.V., Hermsen, C., Smits-van Prooije, A.E., Vermeij-Keers, C.,
1985. Cell degeneration and mitosis in the buccopharyngeal and branchial
membranes in the mouse embryo. Anat. Embryol. 171, 187–192.
Sinha, S., Chen, J.K., 2006. Purmorphamine activates the hedgehog pathway by
targeting Smoothened. Nat. Chem. Biol. 2, 29–30.
Sive, H.L., Grainger, R.M., Harland, R.M., 2000. Early Development of Xenopus
laevis: a laboratory manual. Cold Spring Harbor Laboratory Press.
Soukup, V., Horácek, I., Cerny, R., 2013. Development and evolution of the
vertebrate primary mouth. J. Anat. 222, 79–99.
Standring, S., 2009. Gray's Anatomy, the anatomical basis of clinical practice (40th
Edition). Churchill Livingstone, Elsevier, London.
Stanton, B.Z., Peng, L.F., 2010. Small-molecule modulators of the sonic hedgehog
signaling pathway. Mol. Biosyst. 6, 44–54.
Takahama, H., Sasaki, F., Watanabe, K., 1988. Morphological changes in the oral
(buccopharyngeal) membrane in urodelan embryos: development of the
mouth opening. J. Morphol. 195, 59–69.
Theiler, K., 1969. On the anlage of the fore-gut in the house mouse and the
formation of furrows on the surgace of the egg-cylinder. Z. Anat. Entwick-
lungsgesch. 128, 40–46.
Varnat, F., Zacchetti, G., Altaba, A.R.I., 2010. Hedgehog pathway activity is required
for the lethality and intestinal phenotypes of mice with hyperactive Wnt
signaling. Mech. Dev. 127, 73–81.
Verma, S.P., Geller, K., 2009. Persistent buccopharyngeal membrane: report of a
case and review of the literature. Int. J. Pediatr. Otorhinolaryngol. 73, 877–880.
Wang, C., Rüther, U., Wang, B., 2007. The Shh-independent activator function of the
full-length Gli3 protein and its role in vertebrate limb digit patterning. Dev.
Biol. 305, 460–469.
Watanabe, K., Sasaki, F., Takahama, H., 1984. The ultrastructure of oral (buccophar-
yngeal) membrane formation and rupture in the anuran embryo. Anat. Rec. 210,
513–524.
Waterman, R.E., 1977. Ultrastructure of oral (buccopharyngeal) membrane forma-
tion and rupture in the hamster embryo. Dev. Biol. 58, 219–229.
Waterman, R.E., 1985. Formation and perforation of closing plates in the chick
embryo. Anat. Rec. 211, 450–457.
Waterman, R.E., Schoenwolf, G.C., 1980. The ultrastructure of oral (buccopharyn-
geal) membrane formation and rupture in the chick embryo. Anat. Rec. 197,
441–470.
Wheway, G., Abdelhamed, Z., Natarajan, S., Toomes, C., Inglehearn, C., Johnson, C.A.,
2013. Aberrant Wnt signalling and cellular over-proliferation in a novel mouse
model of Meckel=Gruber syndrome 377, 55–66.
Williams, J.A., Guicherit, O.M., Zaharian, B.I., Xu, Y., Chai, L., Wichterle, H., Kon, C.,
Gatchalian, C., Porter, J.A., Rubin, L.L., et al., 2003. Identiﬁcation of a small
molecule inhibitor of the hedgehog signaling pathway: effects on basal cell
carcinoma-like lesions. Proc. Natl. Acad. Sci. USA 100, 4616–4621.
J.M. Tabler et al. / Developmental Biology 396 (2014) 1–7 7
